David Swift

Executive Director, Market Access Strategic Accounts at Intercept Pharmaceuticals

No bio yet

Links


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Intercept Pharmaceuticals

1 followers

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases.